The global medical devices and diagnostics (MD&D) industry has been undergoing significant globalization and consolidation to serve industrialized nations seeking to provide more care for fewer dollars and emerging nations striving to better serve the health care needs of the new urban classes driving their economic growth. Although total market growth is not expected to return to former double-digit levels, meaningful opportunities in new technologies, geographies and strategic merger & acquisition (M&A) activity are lifting the market out of its recent depressed state. Foreign exchange fluctuations-particularly the impact of a stronger U.S. dollar in which this report is presented-resulted in a small decline in global revenues in 2015; however, this masked real growth in the 4% range for many companies and technologies, evidence of a modest rebound. Going forward, the global MD&D market is projected to increase at a 4.0% real annual rate through 2020. To ensure profitable long-range planning, suppliers must continue to identify opportunities presenting outside of their companies' core focus and act decisively where appropriate. Critical to this process will be a reliable overview of the global MD&D market, including current and forecast sales as well as drivers and limiters of all major technology segments, clinical applications and geographies.
This reliable overview is exactly what Health Research International's "Opportunities in Global Medical Devices & Diagnostics" report provides. Distributed exclusively by Life Science Intelligence, the 550-page document features 200+ exhibits that deliver well-organized, econometrically modeled data encompassing individual market, geographic and competitive assessments for 20 major technology segments -more than 100 individual product markets- for 2014 through 2020. It also quantifies the 13 major clinical applications consuming MD&D products in 2015, and profiles the 26 largest suppliers to the MD&D market using financial exhibits and overviews of their recent M&A activity. (The report's 14-page Table of Contents and List of Exhibits is a must-see to grasp its comprehensive yet detailed nature.) Importantly, the data presented in the report, which are available in Excel format, have been constructed from a meticulous analysis of company revenues by segment, geography and, in some cases, product line as reported in quarterly and annual reports, webcasts, presentations and press releases of more than 400 public and private MD&D companies maintained in HRI's internal company databases.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
